Results 331 to 340 of about 1,156,521 (411)

Genome‐Wide Association Study of Atrial Fibrillation Recurrence After Radiofrequency Catheter Ablation in a Japanese Population

open access: yesJournal of Cardiovascular Electrophysiology, EarlyView.
This study aimed to identify the factors associated with atrial fibrillation (AF) recurrence after catheter ablation. The clinical information analysis revealed persistent AF, nonpulmonary AF triggers, NT‐proBNP levels, and the left atrial volume were clinical predictors of recurrence.
Takumi Sakai   +16 more
wiley   +1 more source

Unilateral Anomalous Pulmonary Venous Return into Coronary Sinus. [PDF]

open access: yesRadiol Cardiothorac Imaging
Subramanian P   +3 more
europepmc   +1 more source

Sotalol Dosing and Outcomes Among Patients Undergoing Intravenous Loading for Atrial Arrhythmias—A PEAKS Registry Substudy

open access: yesJournal of Cardiovascular Electrophysiology, EarlyView.
ABSTRACT Background Sotalol is used for the maintenance of sinus rhythm among patients with atrial fibrillation. However, there is discretion regarding dosing of chronic therapy, and the target oral dose dictates infusion doses for intravenous sotalol loading. To date, use and outcomes by dose are not well‐described.
Benjamin A. Steinberg   +12 more
wiley   +1 more source

Ventricular Tachycardia Ablation in Patients With Severely Decreased Left Ventricular Ejection Fraction

open access: yesJournal of Cardiovascular Electrophysiology, EarlyView.
ABSTRACT Background Ablation of ventricular tachycardia (VT) is often performed in patients with structural heart disease. Procedural and delayed enhancement cardiac magnetic resonance imaging (DE‐CMR) characteristics among patients with very severe cardiomyopathy (CM) and without left‐ventricular assist devices (LVAD) have been incompletely described.
Michael Ghannam   +10 more
wiley   +1 more source

Anatomic considerations in closed transatrial cannulation of the coronary sinus

open access: bronze, 1993
Amram J. Cohen   +3 more
openalex   +1 more source

Home - About - Disclaimer - Privacy